Renaissance Technologies’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-194,500
| Closed | -$1.77M | – | 3673 |
|
|
2018
Q1 | $1.77M | Sell |
194,500
-99,080
| -34% | -$901K | ﹤0.01% | 2389 |
|
|
2017
Q4 | $1.26M | Buy |
293,580
+86,800
| +42% | +$372K | ﹤0.01% | 2577 |
|
|
2017
Q3 | $292K | Buy |
206,780
+86,056
| +71% | +$122K | ﹤0.01% | 2914 |
|
|
2017
Q2 | $181K | Sell |
120,724
-71,837
| -37% | -$108K | ﹤0.01% | 3015 |
|
|
2017
Q1 | $495K | Buy |
192,561
+142,461
| +284% | +$366K | ﹤0.01% | 2774 |
|
|
2016
Q4 | $128K | Sell |
50,100
-138,900
| -73% | -$355K | ﹤0.01% | 3065 |
|
|
2016
Q3 | $584K | Buy |
+189,000
| New | +$584K | ﹤0.01% | 2765 |
|
|
2016
Q2 | – | Sell |
-63,400
| Closed | -$197K | – | 3627 |
|
|
2016
Q1 | $197K | Buy |
63,400
+12,239
| +24% | +$38K | ﹤0.01% | 3095 |
|
|
2015
Q4 | $205K | Sell |
51,161
-21,538
| -30% | -$86.3K | ﹤0.01% | 2990 |
|
|
2015
Q3 | $333K | Sell |
72,699
-313,413
| -81% | -$1.44M | ﹤0.01% | 2736 |
|
|
2015
Q2 | $2M | Buy |
386,112
+7,012
| +2% | +$36.4K | ﹤0.01% | 2057 |
|
|
2015
Q1 | $2.37M | Sell |
379,100
-158,305
| -29% | -$991K | 0.01% | 1839 |
|
|
2014
Q4 | $3.38M | Buy |
537,405
+425,705
| +381% | +$2.68M | 0.01% | 1505 |
|
|
2014
Q3 | $679K | Sell |
111,700
-98,500
| -47% | -$599K | ﹤0.01% | 2208 |
|
|
2014
Q2 | $1.39M | Buy |
+210,200
| New | +$1.39M | ﹤0.01% | 1913 |
|
|
2013
Q4 | – | Sell |
-70,400
| Closed | -$938K | – | 3108 |
|
|
2013
Q3 | $938K | Buy |
70,400
+43,900
| +166% | +$585K | ﹤0.01% | 2041 |
|
|
2013
Q2 | $348K | Buy |
+26,500
| New | +$348K | ﹤0.01% | 2362 |
|